Inventor · disambiguated record
Andrew M. Siwkowski
Also filed as: SIWKOWSKI ANDREW · SIWKOWSKI ANDREW M
31 granted patents·18 pending applications·1,228 citations·filing 1995–2023
98Inventor score
Files withISIS PHARMACEUTICALS INC16IONIS PHARMACEUTICALS INC10BHANOT SANJAY6SWAYZE ERIC E5FREIER SUSAN M3
Top patents by PatentIndex Score
49 records- 0199US9005906B2Tetrahydropyran nucleic acid analogsISIS PHARMACEUTICALS INC·Filed 2014·Granted Apr 14, 2015·163 cites·24 claims
- 0299US8440803B2Tetrahydropyran nucleic acid analogsSWAYZE ERIC E·Filed 2011·Granted May 14, 2013·158 cites·16 claims
- 0399US7745609B2Antisense modulation of CD40 expressionISIS PHARMACEUTICALS INC·Filed 2006·Granted Jun 29, 2010·189 cites·46 claims
- 0498US9617540B2Compounds and methods for modulating gene expressionIONIS PHARMACEUTICALS INC·Filed 2015·Granted Apr 11, 2017·26 cites·20 claims
- 0598US9045754B2Short antisense compounds with gapmer configurationBHANOT SANJAY·Filed 2007·Granted Jun 2, 2015·56 cites·44 claims
- 0698US8846639B2Oligomeric compounds comprising bicyclic nucleosides and having reduced toxicitySWAYZE ERIC E·Filed 2009·Granted Sep 30, 2014·56 cites·15 claims
- 0798US8796437B2Tetrahydropyran nucleic acid analogsISIS PHARMACEUTICALS INC·Filed 2013·Granted Aug 5, 2014·85 cites·23 claims
- 0898US8088904B2Tetrahydropyran nucleic acid analogsSWAYZE ERIC E·Filed 2008·Granted Jan 3, 2012·164 cites·30 claims
- 0997US8143230B2Compounds and methods for modulating expression of PCSK9BHANOT SANJAY·Filed 2007·Granted Mar 27, 2012·44 cites·46 claims
- 1096US8697860B1Diagnosis and treatment of diseaseISIS PHARMACEUTICALS INC·Filed 2013·Granted Apr 15, 2014·25 cites·16 claims
- 1196US7919472B2Enhanced antisense oligonucleotidesISIS PHARMACEUTICALS INC·Filed 2005·Granted Apr 5, 2011·37 cites·20 claims
- 1295US9399774B2Modulation of transthyretin expressionIONIS PHARMACEUTICALS INC·Filed 2015·Granted Jul 26, 2016·13 cites·40 claims
- 1395US8188059B2Compounds and methods for modulating expression of GCGRBHANOT SANJAY·Filed 2007·Granted May 29, 2012·22 cites·36 claims
- 1494US8334372B2Modulation of factor 11 expressionFREIER SUSAN M·Filed 2009·Granted Dec 18, 2012·21 cites·57 claims
- 1593US8586554B2Compounds and methods for modulating expression of PTP1BBHANOT SANJAY·Filed 2007·Granted Nov 19, 2013·13 cites·45 claims
- 1692US9816092B2Modulation of transthyretin expressionIONIS PHARMACEUTICALS INC·Filed 2016·Granted Nov 14, 2017·7 cites·8 claims
- 1788US8372967B2Compounds and methods for modulating expression of GCCRISIS PHARMACEUTICALS INC·Filed 2007·Granted Feb 12, 2013·5 cites·75 claims
- 1886US11535849B2Modulation of transthyretin expressionIONIS PHARMACEUTICALS INC·Filed 2020·Granted Dec 27, 2022·1 cites·10 claims
- 1986US8673871B2Compounds and methods for modulating expression ApoBBHANOT SANJAY·Filed 2007·Granted Mar 18, 2014·4 cites·19 claims
- 2084US8993528B2Oligomeric compounds comprising tricyclic nucelosides and methods for their useISIS PHARMACEUTICALS INC·Filed 2013·Granted Mar 31, 2015·2 cites·20 claims
- 2184US8735370B2Modulation of factor 11 expressionISIS PHARMACEUTICALS INC·Filed 2012·Granted May 27, 2014·4 cites·30 claims
- 2284US2023263822A1Modulation of factor 11 expressionIONIS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2383US8362232B2Compounds and methods for modulating expression of SGLT2ISIS PHARMACEUTICALS INC·Filed 2010·Granted Jan 29, 2013·3 cites·46 claims
- 2482US8389488B2Antidotes to antisense compoundsMONIA BRETT P·Filed 2008·Granted Mar 5, 2013·3 cites·18 claims
- 2580US5683902AHuman papilloma virus inhibition by a hairpin ribozymeUNIV NORTHERN ILLINOIS·Filed 1995·Granted Nov 4, 1997·58 cites·8 claims
- 2679US8084436B2Modulation of SGLT2 expressionFREIER SUSAN M·Filed 2008·Granted Dec 27, 2011·3 cites·54 claims
- 2779US5646031ASArMV and sCYMVI hairpin ribozymesUNIV NORTHERN ILLINOIS·Filed 1995·Granted Jul 8, 1997·55 cites·6 claims
- 2877US8969316B2Compounds and methods for modulating expression of DGAT2ISIS PHARMACEUTICALS INC·Filed 2012·Granted Mar 3, 2015·1 cites·20 claims
- 2975US9428750B2Oligomeric compounds comprising tricyclic nucleosides and methods for their useIONIS PHARMACEUTICALS INC·Filed 2015·Granted Aug 30, 2016·1 cites·18 claims
- 3075US8426378B2Oligomeric compounds comprising tricyclic nucelosides and methods for their useSWAYZE ERIC E·Filed 2009·Granted Apr 23, 2013·0 cites·6 claims
- 3174US11376273B2Modulation of factor 11 expressionIONIS PHARMACEUTICALS INC·Filed 2020·Granted Jul 5, 2022·0 cites·20 claims
- 3271US8258105B2Antisense oligonucleotides optimized for kidney targetingSIWKOWSKI ANDREW M·Filed 2004·Granted Sep 4, 2012·9 cites·25 claims
- 3369US2019169613A1Modulation of transthyretin expressionIONIS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 3468US2015057329A1Compounds and methods for modulating expression apobISIS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 3565US2018273946A1Modulation of transthyretin expressionIONIS PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 3665US2016010086A1Oligomeric compounds and excipientsISIS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 3763US2012208864A1Compounds and methods for modulating expression of gcgrBHANOT SANJAY·Filed 2012·Application pending·0 cites
- 3861US2013190384A1Modulation of factor 11 expressionISIS PHARMACEUTICALS INC·Filed 2012·Application pending·0 cites
- 3959US2017035798A1Modulation of factor 11 expressionIONIS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 4059US2015141636A1Oligomeric compounds comprising bicyclic nucleosides and having reduced toxicityISIS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 4159US2011294868A1Modulation of transthyretin expressionMONIA BRETT P·Filed 2011·Application pending·0 cites
- 4257US2004186071A1Antisense modulation of CD40 expressionFiled 2003·Application pending·0 cites
- 4355US2013296400A1Antidotes to antisense compoundsISIS PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 4454US2005191653A1Modulation of SGLT2 expressionFiled 2004·Application pending·0 cites
- 4553US2012264806A1Oligomeric compounds and excipientsBENNETT C FRANK·Filed 2010·Application pending·0 cites
- 4650US2012196921A1Modulation of sglt-2 expressionFREIER SUSAN M·Filed 2011·Application pending·0 cites
- 4748US2007299028A1Backbone modifications to modulate oligonucleotide targeting in vivoSIWKOWSKI ANDREW M·Filed 2007·Application pending·0 cites
- 4846US2011207797A1Enhanced antisense oligonucleotidesISIS PHARMACEUTICALS INC·Filed 2011·Application pending·0 cites
- 4938US2012021515A1Oligomeric compounds and methodsSWAYZE ERIC E·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andrew M. Siwkowski files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →